Intraoperative Balloon Angioplasty for Chronic Portal Vein Thrombosis in Liver Transplantation

TO THE EDITOR:
Nowadays portal vein thrombosis (PVT) is no longer considered an absolute contraindication for liver transplantation (LT). However, PVT is associated with worse outcomes and represents a risk factor for 90-day mortality and graft failure after LT. (1) To minimize post-LT complications, it is of utmost importance to establish an adequate portal flow at the end of LT to ensure optimal graft function. (1, 2) In recent years, many surgical procedures have been described to manage PVT intraoperatively, posing a challenge to the transplant surgeon. On one side, depending on the extension of the PVT, different reconstruction techniques have been described. (2) The best outcomes after LT are achieved when portomesenteric venous circulation is physiologically reestablished. (1) In this setting, post-LT evolution may be comparable to patients without PVT. Besides technical reconstruction of the portal flow, another intraoperative item that has an influence on post-LT outcome is the management of spontaneous portosystemic shunts (SPSSs). The ligation of large SPSS helps adequately revascularize the graft and improves short-term and longterm outcomes when compared with no shunt ligation. (3) Balloon angioplasty as a treatment for PVT has been described in the setting of LT and other hepatic or pancreatic surgeries and is considered to be safe and effective. (4) The usual scenario is the placement of a percutaneous transhepatic catheter in the portal vein (PV) for balloon dilatation or stent placement in the postoperative period.
We propose the use of intraoperative balloon angioplasty directly within the PV when facing the absence of portal flow due to a fibrotic or stenosed PV, with the association of large SPSS ligation if deemed necessary. To our knowledge, this technique has not been published elsewhere before.
Patients and Methods
Between May 2017 and May 2018, we performed 53 LTs at our institution. Of those, 9 patients had preoperative PVT seen on computed tomography (CT) scan. According to the classification from Yerdel et al., (5) 7 patients had grade 1-2 PVT, and 2 patients had grade 3 PVT. All patients with grade 1-2 PVT were managed intraoperatively with thrombectomy and end-toend anastomosis. We selected 2 patients with grade 3 PVT as potential candidates for this procedure.
The first patient was a 62-year-old male with hepatitis C cirrhosis. The preoperative CT scan showed a complete chronic PVT with portal hypertension, esophageal varices, and spontaneous splenorenal shunt. The PV was filiform and with cavernous transformation, which was suggestive of chronic thrombosis. Therefore, no anticoagulation therapy was initiated because it was considered futile (Fig. 1A) .
The second patient was a 59-year-old female with autoimmune cirrhosis and a small nodule of hepatocellular carcinoma. While on the waiting list for LT, the patient was diagnosed with an acute PVT with the extension of the thrombus to the superior mesenteric vein (SMV). Although anticoagulation therapy Letters from the frontLine | 337 was initiated 4 months before LT, she later developed chronic PVT with a large splenorenal shunt and esophageal varices (Fig. 1C) .
At the time of LT, due to the chronicity of the thrombosis, these 2 patients had a fibrotic PV and splenomesenteric confluence that were without blood flow. No thrombus was found in the PV. Direct anastomosis between the donor PV and the recipient's confluence of the SMV and splenic vein was not possible due to the intraoperative finding that the fibrosis extended below this point. Those were the patients in whom balloon angioplasty was performed.
sUrGiCaL strateGY
The PV was identified, dissected, and sectioned. After confirming that no adequate portal flow was present because of a fibrotic vein, a balloon angioplasty was then indicated.
A Mustang balloon dilatation catheter (12-mm diameter, 40-mm length, Boston Scientific, Marlborough, MA) was inserted in the PV and advanced following the SMV. The proximal margin of the balloon remained in the PV, just above the SMV and splenic confluence. Balloon pressure was slowly elevated using an inflation syringe (Encore, Boston Scientific) with a pressure limit of 10 atmospheres for 30 seconds to 1 minute, until portal flow was present. After balloon dilatation, the vein was heparinized and then clamped to continue with the procedure (Fig. 2 ).
The recipient hepatectomy was then completed, and the donor liver graft was placed and sutured to the hepatic veins. An end-to-end PV anastomosis was performed using a 5-0 polypropylene running suture. Final portal flow was confirmed by intraoperative portal flow measurement at the end of the procedure. If portal flow was under 1 L/minute (or 80 mL/ minute/100 g of liver weight) and the patient had a large SPSS, then the shunt was clamped, and portal 
postoperative foLLoW-Up
Postoperative venous patency was evaluated routinely using Doppler ultrasound (DUS) at 24 hours, 1 week, 1 month, and 3 months after LT. All patients were anticoagulated with low-molecular-weight heparin after LT. Before withdrawing anticoagulant treatment, a CT scan was performed to rule out PV stenosis or rethrombosis, usually at 3 months after LT (Fig. 1B,D) .
Results
Balloon angioplasty was feasible in both patients achieving portal flow after the dilatation. An end-toend portal anastomosis was then performed, and venous flows were measured. In both cases, portal flow was under 1 L/minute (or 80 mL/minute/100 g of liver weight), and large spontaneous splenorenal shunts were present. Portal flow improved after test clamping the left renal vein on the left border of the IVC, so in both cases the left renal vein was ligated. In the later patient, a clamping test was performed for a large coronary vein, but the portal flow remained the same, so the collateral vein was not ligated.
Outcomes of LT were uneventful. No primary nonfunction, primary dysfunction, or encephalopathy episodes were recorded. Portal flow patency was reevaluated with DUS systematically and with a CT scan at 3 months after LT. No PV rethrombosis or stenosis was observed in either patient (follow-up at 12 months and 4 months, respectively).
Discussion
PVT is a common complication in patients waiting for a LT with a prevalence ranging from 6% to 12% of patients. (1) (2) (3) (4) (5) Its presence can make LT more difficult, especially with higher grades of PVT where elaborate reconstruction techniques to restore portal flow may be necessary. (2) Besides, PVT that has not resolved with anticoagulation in the preoperative period usually evolves into chronic PVT with fibrosis and stenosis of the PV. This subset of patients is not clearly defined in Yerdel's classification of PVT. (5) According to Hibi et al. (1) depending on the technique used to restore portal flow, different post-LT outcomes can be expected. When portomesenteric venous circulation is physiologically re-established (end-toend PV or SMV anastomoses, interpositional vein grafting, extra-anatomical mesoportal jump grafting, and anastomoses to dilated portal venous tributaries), post-LT evolution is comparable to patients without PVT. On the contrary, the need for a nonphysiological reconstruction technique (renoportal anastomosis, cavoportal hemitransposition, or PV arterialization) is Letters from the frontLine | 339 associated with higher complication rates and inferior patient and graft survival. (1) Here lies the importance of using every method at our disposal to restore a physiological portal flow.
Intraoperative management of PVT at our institution was described 10 years ago by Lladó et al. (2) One of the main problems the transplant surgeon may encounter in patients with PVT is not finding an adequate vein to perform the anastomosis that will restore portal flow to the liver graft. Balloon angioplasty allows the use of a fibrotic PV with a variable degree of stenosis that otherwise would be inadequate. Indeed, the association between a fibrotic PV and large SPSS may predispose a patient to low portal blood flow and consequently postoperative rethrombosis.
Percutaneous transhepatic balloon angioplasty is a technique that has been used to treat PV thrombosis for a long time by interventional radiologists and is considered to be safe and effective. (4) Usually, it is performed postoperatively when a CT scan shows a PVT with or without narrowing of the PV. The novelty of our approach is the use of the same technique intraoperatively that is used percutaneously, with the aim to model the PV and improve its anatomy so that a venous anastomosis can be performed. Thus, this technique may possibly enable a physiological portal reconstruction in patients who otherwise could be doomed to a nonphysiological reconstruction. We consider patients who will most likely benefit from this procedure are patients with Yerdel's grade 2 (>50% PVT and minimal obstruction of SMV) and grade 3 (complete PVT and proximal SMV thrombosis) PVT. (5) Patients for whom we would not consider this technique are those in whom a thrombectomy can be performed with restoration of blood flow, making the angioplasty unnecessary, and those with Yerdel's grade 4 PVT (complete PV and entire SMV thrombosis) because angioplasty would not be resolutive. The use of a short venous interposition graft to the SMV can be an alternative, but we believe balloon angioplasty is an easier option because it allows for a single portal anastomosis instead of the 2 anastomoses that are necessary for an interpositional graft. If balloon angioplasty is not successful in restoring the portal flow, a venous interposition graft remains a reconstruction option.
Articles in the literature describing intraoperative management of PVT often only focus on technical aspects of PV reconstruction. Most patients with chronic PVT may have significant SPSS. So, to achieve an adequate portal flow at the end of LT, it is equally important to evaluate the presence of SPSS intraoperatively. When portal flow is <1 L/minute (or 80 mL/ minute/100 g of liver weight), a clamping test of any major SPSS is mandatory. If portal flow improves after clamping of the SPSS, ligation of the shunt is advised. A study by Gomez Gavara et al. (3) showed that large SPSS ligation was associated with lower postoperative morbidity, a decreased rate of encephalopathy, and a trend toward a lower rate of PVT. In the long term, patient and graft survival rates were also better in the ligated shunt group compared with the nonligated shunt group.
In conclusion, patients with chronic PVT who develop fibrosis and stenosis of the PV and, as a result, have an unsuitable vein for anastomosis, can benefit from balloon angioplasty of the PV, hence allowing an end-to-end portal anastomosis. Addition of large SPSS ligation in patients with low portal blood flow can help adequately revascularize the liver graft, therefore improving patient and graft survival rates.
